Aspire Biopharma Holdings, Inc. (ASBP)

1.80 -0.01 (-0.55%) USD  |  NASDAQ  |  Jan 23, 11:43
More

Aspire Biopharma Holdings EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ASBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Plus Therapeutics, Inc. Upgrade
Decoy Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
Invivyd, Inc. --
Acrivon Therapeutics, Inc. --